Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial

References

• Steiner TJ, Stovner LJ, Vos T, et al. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain. 2018;19:17.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–349.
   PubMed Web of Science ®Google Scholar
• Victor TW, Hu X, Campbell J, et al. Association between migraine, anxiety and depression. Cephalalgia. 2010;30:567–575.
   PubMed Web of Science ®Google Scholar
• Tepper NK, Whiteman MK, Zapata LB, et al. Safety of hormonal contraceptives among women with migraine: a systematic review. Contraception. 2016;94:630–640.
   PubMed Web of Science ®Google Scholar
• Champaloux SW, Tepper NK, Monsour M, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;216:489.e1–489.e7.
   PubMed Web of Science ®Google Scholar
• Sacco S, Merki-Feld GS, Aegidius KL, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017;18:108.
   PubMed Web of Science ®Google Scholar
• Sacco S, Merki-Feld GS, Aegidius KL, et al. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). J Headache Pain. 2018;19:76.
   PubMed Web of Science ®Google Scholar
• Close LN, Eftekhari S, Wang M, et al. Cortical spreading depression as a site of origin for migraine: role of CGRP. Cephalalgia. 2019;39:428–434.
   PubMed Web of Science ®Google Scholar
• Somerville B. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22:355–365.
   PubMed Web of Science ®Google Scholar
• Nattero G, Allais G, De Lorenzo C, et al. Relevance of prostaglandins in true menstrual migraine. Headache. 1989;29:233–238.
   PubMed Web of Science ®Google Scholar
• MacGregor EA. “Menstrual” migraine: towards a definition. Cephalalgia. 1996;16:11–21.
   PubMed Web of Science ®Google Scholar
• Granella F, Sances G, Allais G, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia. 2004;24:707–716.
   PubMed Web of Science ®Google Scholar
• Vetvik KG, Benth JS, MacGregor EA, et al. Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine. Cephalalgia. 2015;35:1261–1268.
   PubMed Web of Science ®Google Scholar
• Pavlovic JM, Stewart WF, Bruce CA, et al. Burden of migraine related to menses: results from the AMPP study. J Headache Pain. 2015;16:24.
   PubMed Web of Science ®Google Scholar
• Lionetto L, Fiorillo M, Martelletti P. Efficacy and tolerability of almotriptan in menstrual migraine: a comment. Expert Opin Pharmacother. 2011;12:2279–2281.
   PubMed Web of Science ®Google Scholar
• Hu Y, Guan X, Fan L, et al. Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. J Headache Pain. 2013;14:7.
   PubMed Web of Science ®Google Scholar
• Negro A, Napoletano F, Lionetto L, et al. Treatment of menstrual migraine: utility of control of related mood disturbances. Expert Rev Neurother. 2014;14:493–502.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Imthurn B, Langner R, et al. Headache frequency and intensity in female migraineurs using desogestrel-only contraception: a retrospective pilot diary study. Cephalalgia. 2013;33:340–346.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Imthurn B, Langner R, et al. Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days. J Headache Pain. 2015;16:522.
   PubMed Web of Science ®Google Scholar
• Morotti M, Remorgida V, Venturini PL, et al. Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study. Eur J Obstet Gynecol Reprod Biol. 2014;183:178–182.
   PubMed Web of Science ®Google Scholar
• Teepker M, Peters M, Kundermann B, et al. The effects of oral contraceptives on detection and pain thresholds as well as headache intensity during menstrual cycle in migraine. Headache. 2011;51:92–104.
   PubMed Web of Science ®Google Scholar
• Aegidius K, Zwart JA, Hagen K, et al. Oral contraceptives and increased headache prevalence: the Head-HUNT Study. Neurology. 2006;66:349–353.
   PubMed Web of Science ®Google Scholar
• Massiou H, MacGregor EA. Evolution and treatment of migraine with oral contraceptives. Cephalalgia. 2000;20:170–174.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Sances G, Allais G, et al. Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study. Contraception. 2011;83:223–228.
   PubMed Web of Science ®Google Scholar
• Warhurst S, Rofe CJ, Brew BJ, et al. Effectiveness of the progestin-only pill for migraine treatment in women: a systematic review and meta-analysis. Cephalalgia. 2018;38:754–764.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Rapoport AM, Lipton RB, et al. Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43:336–342.
   PubMed Web of Science ®Google Scholar
• Schurks M, Buring JE, Kurth T. Migraine, migraine features, and cardiovascular disease. Headache. 2010;50:1031–1040.
   PubMed Web of Science ®Google Scholar
• Allais G, Chiarle G, Sinigaglia S, et al. Estrogen, migraine, and vascular risk. Neurol Sci. 2018;39:11–20.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Esguevillas G, Serrador M, et al. Gamma-aminobutyric acid (GABA) receptors GABRA4, GABRE, and GABRQ gene polymorphisms and risk for migraine. J Neural Transm (Vienna). 2018;125:689–698.
   PubMed Web of Science ®Google Scholar
• Edvinsson L. Role of CGRP in migraine. Handb Exp Pharmacol 2019. DOI:10.1007/164_2018_201
   PubMedGoogle Scholar
• Labastida-Ramírez A, Rubio-Beltrán E, Villalón CM, et al. Gender aspects of CGRP in migraine. Cephalalgia. 2019;39:435–444.
   PubMed Web of Science ®Google Scholar
• Joshi G, Pradhan S, Mittal B. Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia. 2010;30:311–320.
   PubMed Web of Science ®Google Scholar
• Lidegaard O, Lokkegaard E, Jensen A, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366:2257–2266.
   PubMed Web of Science ®Google Scholar
• El Amki M, Binder N, Steffen R, et al. Contraceptive drugs mitigate experimental stroke-induced brain injury. Cardiovasc Res. 2019;115:637–646.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Imthurn B, Seifert B, et al. Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine. Eur J Contracept Reprod Health Care. 2013;18:394–400.
   PubMed Web of Science ®Google Scholar
• Prange-Kiel J, Rune GM, Zwirner M, et al. Regulation of estrogen receptor alpha and progesterone receptor (isoform A and B) expression in cultured human endometrial cells. Exp Clin Endocrinol Diabetes. 2001;109:231–237.
   PubMed Web of Science ®Google Scholar
• Aguirre C, Jayaraman A, Pike C, et al. Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-β. J Neurochem. 2010;115:1277–1287.
   PubMed Web of Science ®Google Scholar
• Jayaraman A, Pike CJ. Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol. 2009;21:77–81.
   PubMed Web of Science ®Google Scholar
• Poisbeau P, Keller AF, Aouad M, et al. Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone. Front Cell Neurosci. 2014;8:174.
   PubMed Web of Science ®Google Scholar